Synonyms:inositol, myo-inositol, Scyllo-inositol, epi-Inositol, Muco-Inositol, Allo-inositol, i-Inositol, 87-89-8, meso-Inositol, Neo-inositol, 1D-Chiro-inositol, 1L-Chiro-inositol, D-(+)-chiro-Inositol, cis-Inositol, 643-12-9, 488-59-5, D-chiro-Inositol, Myoinositol, Scyllitol, 6917-35-7, Cyclohexane-1,2,3,4,5,6-hexaol, cyclohexane-1,2,3,4,5,6-hexol, 488-58-4, Quercinitol, mesoinositol, Cocositol, 551-72-4, Meat sugar, Myoinosite, Dambose, chiro-inositol, Inositene, Inositina, L-chiro-Inositol, Phaseomannite, Inosital, Inosite, Iso-inositol, Cyclohexitol, Phaseomannitol, 41546-34-3, Inositol, myo-, Mesoinosit, Mesoinosite, Scyllite, Mesovit, Nucite, Mesol, 643-10-7, 488-55-1, Cyclohexanehexol, Inositol, meso-, cis-1,2,3,5-trans-4,6-Cyclohexanehexol, D-myo-Inositol, D-chiro Inositol, 488-54-0, Bios I, Insitolum, Isoinositol, L-(-)-chiro-Inositol, (-)-Inositol, 576-63-6, d-Inositol, L-Inositol, L-myo-Inositol, Inositol, allo-, Inositol, muco-, Inositol, i-, Inositol, scyllo-, Inositol (VAN), alloinositol, neoinositol, Hexahydroxycyclohexane, scyllo-Cyclohexanehexol, 1D-myo-Inositol, 1L-myo-Inositol, Inositol, cis-, Inositol, epi-, Inositol, neo-, epi-Cyclohexanehexol, (+)-Inositol, 1,2,3,4,5,6-Cyclohexanehexol, (-)-chiro-Inositol, ELND005, Rat antispectacled eye factor, Levoinositol, CCRIS 6745, 1,2,3,5-trans-4,6-Cyclohexanehexol, cis-, AZD 103, Chiro-inositol, (-)-, Inositol, myo, (1R,2R,3S,4R,5r,6S)-cyclohexane-1,2,3,4,5,6-hexaol, 38876-99-2, MFCD00077932, (1r,2r,3r,4r,5r,6r)-cyclohexane-1,2,3,4,5,6-hexol, 1,3,5/2,4,6-Hexahydroxycyclohexane, (1R,2R,3R,4R,5S,6S)-Cyclohexane-1,2,3,4,5,6-hexaol, (1R,2R,3S,4S,5S,6S)-Cyclohexane-1,2,3,4,5,6-hexaol, 1-L-chiro-Inositol, Inositol, D-chiro-, (+)-Chiro-Inositol, CHEBI:17268, AI3-16111, NSC8101, 1,3,5/2,4,6-cyclohexanehexol, 1,2,3,5/4,6-Cyclohexanehexol, NSC 8101, NSC-8101, Chiro-inositol, (+)-, (1r,2R,3S,4r,5R,6S)-cyclohexane-1,2,3,4,5,6-hexol, (1R,2R,3R,4S,5S,6s)-cyclohexane-1,2,3,4,5,6-hexaol, (1R,2R,3S,4S,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, 1,2,3,4,5,6-HEXAHYDROXY-CYCLOHEXANE, NSC-25142, NSC-55551, NSC404118, myo-Inositol;meso-Inositol, NSC 404118, NSC-404118, J101.890F, J101.891D, (1s,2s,3s,4s,5s,6s)-cyclohexane-1,2,3,4,5,6-hexol, 63GQX5QW03, 8LQ63P85IC, 9O6Y5O4P9W, ELND-005, R1Y9F3N15A, (1R,2R,3R,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, (1r,2R,3R,4s,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, (1s,2R,3R,4s,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, DTXSID7023146, CHEBI:10642, CHEBI:23927, CHEBI:27372, CHEBI:27987, AZD-103, 4661D3JP8D, 6R79WV4R10, M94176HJ2F, Inositol (VAN8C, NSC45517, NSC55551, NSC55552, NSC-55552, NSC-55558, 1VS4X81277, NSC-103959, NSC-127230, INS, NCGC00159409-02, (1R,2R,3S,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexaol, (1R,2R,3S,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, (1r,2R,3S,4s,5R,6S)-cyclohexane-1,2,3,4,5,6-hexol, 4L6452S749, 587A93P465, Inositol, myo- (8CI), MYO-INOSITOL-1,2,3,4,5,6-D6, 1,3,4,5,6-Cyclohexanehexol, 1,3,5/4,6-Cyclohexanehexol, DTXCID2065254, 1,2,4/3,5,6-cyclohexanehexol, rel-(1r,2r,3r,4r,5r,6r)-Cyclohexane-1,2,3,4,5,6-hexaol, rel-(1R,2r,3S,4R,5s,6S)-Cyclohexane-1,2,3,4,5,6-hexaol, Mouse antialopecia factor, 1,2,3,4,5,6-Cyclohexanehexol #, cis-1,2,3,4,5,6-cyclohexanehexol, CAS-87-89-8, cis-1,3,5-trans-4,6-Cyclohexanehexol, SMR000857145, SMR000857319, SMR000857320, Inositol NF 12, ELND 005, SR-05000001655, EINECS 201-781-2, MFCD00065455, 1,2,3,4,5,6-Hexahydroxycyclohexane, inositols, UNII-63GQX5QW03, UNII-8LQ63P85IC, UNII-9O6Y5O4P9W, UNII-R1Y9F3N15A, an inositol, Inositol [Nonspecific isomer], UNII-4661D3JP8D, UNII-6R79WV4R10, UNII-M94176HJ2F, Muscle sugar, inositol myo-, D-muco-Inositol, UNII-1VS4X81277, Inositol FCC, 4irx, Inositol, chiro-, rac-chiro-inositol, UNII-4L6452S749, UNII-587A93P465, Inosital (TN), Inositol (NF), CBU, EINECS 207-681-5, EINECS 207-682-0, EINECS 209-000-7, EINECS 211-393-5, EINECS 211-394-0, EINECS 230-024-9, NSC 25142, EPIINOSITOL, (+)-Epi-Inositol, CHIRO-INOSITOLS, Epi-inositol, 98%, allo-Inositol, 97%, Inositol [USAN:NF], INOSITOL, MESO, Spectrum_001595, 2os9, INOSITOL [INCI], INOSITOL [USAN], INOSITOL [FCC], INOSITOL [INN], orthorhombic myo-inositol, D-(+)-Chiro Inositol, DL-CHIRO-INOSITOL, INOSITOL [MI], INOSITOL (D), INOSITOL (L), INOSITOL [VANDF], Spectrum3_001053, Spectrum4_001193, Spectrum5_000961, myo-Inositol, >=99%, INOSITOL [MART.], bmse000102, bmse000103, bmse000113, bmse000901, bmse000922, Epitope ID:144993, INOSITOL [USP-RS], INOSITOL [WHO-DD], scyllo-Inositol, >=98%, SCHEMBL5831, SCHEMBL5832, SCHEMBL5969, NCIOpen2_008191, BSPBio_002606, KBioGR_001885, KBioSS_002075, MLS001332377, MLS001332378, MLS001335965, MLS001335966, MLS001335967, MLS001335968, SCHEMBL187278, SCHEMBL187397, SCHEMBL187796, SCHEMBL188106, SCHEMBL188237, SCHEMBL491333, SCHEMBL959404, SCHEMBL959405, CHEMBL278373, CHEMBL468154, GTPL4495, GTPL4645, GTPL4648, GTPL4649, MEGxp0_001817, SCHEMBL1055883, SCHEMBL4748543, SCHEMBL6378921, SCHEMBL6468882, SCHEMBL6791918, CHEMBL1222251, CHEMBL1231671, CHEMBL1950780, CHEMBL3976780, SCHEMBL12371461, SCHEMBL12377889, SCHEMBL12411898, SCHEMBL12711208, SCHEMBL12735687, SCHEMBL13058696, SCHEMBL13114115, SCHEMBL13114116, SCHEMBL13114128, SCHEMBL13207905, SCHEMBL13580047, SCHEMBL14542470, SCHEMBL21388397, ACon1_002457, CHEBI:22357, CHEBI:23311, CHEBI:24848, CHEBI:25492, CHEBI:27374, D-(+)-chiro-Inositol, 95%, KBio2_002075, KBio2_004643, KBio2_007211, KBio3_001826, L-(-)-chiro-Inositol, 95%, DTXSID30110000, DTXSID50905091, myo-Inositol, p.a., 98.0%, 1,2,3,4,5/6-cyclohexanehexol, 1,2,3,4/5,6-cyclohexanehexol, 1,2,3/4,5,6-cyclohexanehexol, 1,2,4,5/3,6-cyclohexanehexol, DTXSID101028818, DTXSID101028820, DTXSID201028823, DTXSID301028826, DTXSID601028825, DTXSID901028824, HMS2091N13, HMS2230N03, HMS2235H05, HMS2235M23, HMS3369B06, HMS3369F20, HMS3373E05, Pharmakon1600-01500352, D-CHIRO-INOSITOL [USP-RS], D-CHIRO-INOSITOL [WHO-DD], 1,2,3,4,5,6-Cyclohexanehexaol, BCP25172, HY-B1411, HY-N3021, MYO-INOSITOL [EP MONOGRAPH], NSC25142, NSC55558, D-myo-Inositol, Cell Culture Grade, Tox21_111642, Tox21_302035, CCG-36096, cis-Inositol, >=98.0% (TLC), MFCD00003863, MFCD00272608, MFCD00799555, MFCD00799556, MFCD01321249, NSC 55552, NSC 55558, NSC-45517, NSC103959, NSC127230, NSC757076, s4530, STL453612, epi-Inositol, >=98.0% (HPLC), 1,2,3,4,5,6/0-cyclohexanetetrol, AKOS006240678, AKOS006332036, AKOS015895894, AKOS015912905, AKOS015912934, AKOS015960429, AKOS015960633, AKOS015994742, AKOS024318869, Tox21_111642_1, CS-4782, CS-W010757, CS-W017225, DB03106, DB13178, DB15350, HY-W010041, HY-W016509, HY-W021265, HY-W127726, J9.771C, KS-1284, KS-1420, NSC 103959, NSC 127230, NSC-757076, SB44732, SB45039, SB46764, SB46855, D-chiro-Inositol, >=98.0% (HPLC), NCGC00159409-03, NCGC00159409-04, NCGC00169828-01, NCGC00178580-01, NCGC00178580-03, NCGC00255362-01, AC-11070, AS-10616, AS-68396, AS-68424, cyclohexane-1R,2R,3S,4S,5R,6S-hexol, LS-13189, NCI60_041778, SY060836, myo-Inositol, purum, >=98.0% (HPLC), rac-chiro-1,2,3,4,5,6-cyclohexanehexol, SBI-0051369.P003, cis-1,2,4-trans-3,5,6-Cyclohexanehexol, DB-051583, DB-051584, DB-054642, HY-121962, J101.888D, J101.889B, J101.892B, myo-Inositol, for microbiology, >=99.0%, CS-0023004, CS-0083766, CS-0369552, FT-0627237, FT-0632208, FT-0632209, FT-0632730, FT-0652045, FT-0670351, FT-0670357, FT-0693444, FT-0693614, I0040, I0628, I0629, I0630, I0631, I0632, I0633, S6176, EN300-82941, myo-Inositol, BioUltra, >=99.5% (HPLC), myo-Inositol, SAJ special grade, >=99.0%, myo-Inositol, Vetec(TM) reagent grade, 99%, C00137, C06151, C06152, C06153, C19891, D08079, D78450, D91187, D91188, D91189, E78671, EN300-658805, F19572, I-6500, M01914, T72516, AB00051982_13, EN300-7361851, EN300-7411506, A834712, A836375, A866896, EN300-19631206, EN300-19632288, EN300-25914216, Q407997, Q743661, Q-201583, Q2838375, Q2974313, Q3011024, Q3023527, Q3205874, Q3331426, Q3347078, Q3589114, SR-05000001655-1, SR-05000001655-5, W-202861, W-202862, W-203081, W-203168, W-203392, 1,2,4/3,5,6-Cyclohexane-1,2,3,4,5,6-hexol, 7B0CEF84-D9CE-4A88-AA7D-EC50C89387A5, 1D7A27BF-6060-4FA9-AC46-3BD18DBA406E, 220128F1-89BF-442D-AD6D-E6D1EA7BA625, Z1486007281, (1r,2r,3r,4r,5r,6r)-cyclohexane-1,2,3,4,5,6-hexaol, (1R,2S,3r,4R,5S,6r)-cyclohexane-1,2,3,4,5,6-hexol, (1R,2S,3r,4R,5S,6s)-cyclohexane-1,2,3,4,5,6-hexol, (1R,2S,3s,4R,5S,6s)-cyclohexane-1,2,3,4,5,6-hexol, D-MYO-INOSITOL-1,2,5,6-TETRAPHOSPHATE SODIUM SALT, Inositol, United States Pharmacopeia (USP) Reference Standard, myo-Inositol, European Pharmacopoeia (EP) Reference Standard, (1R,2R,3S,4S,5S,6R)-CYCLOHEXANE-1,2,3,4,5,6-HEXOL, 1,2,3,4,5,6-Cyclohexanehexol, (cis,cis,cis,trans,cis,trans)- #, 1,2,3,4,5,6-cyclohexanehexol, (1alpha,2alpha,3alpha,4beta,5alpha,6beta), Inositol, Pharmaceutical Secondary Standard; Certified Reference Material, 1.ALPHA.,2.ALPHA.,3.BETA.,4.ALPHA.,5.BETA.,6.BETA.-CYCLOHEXANEHEXOL, 2H3, myo-Inositol, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture
Pubchem:PUBCHEM:892
Id:1fd737af-b781-5e6e-b929-e9c7520f1e21
Description:nan